Juvenile  ||| S:0 E:9 ||| JJ
idiopathic  ||| S:9 E:20 ||| JJ
arthritis ||| S:20 E:29 ||| NN
.  ||| S:29 E:31 ||| .
Subgroup  ||| S:31 E:40 ||| JJ
characteristics  ||| S:40 E:56 ||| NNS
and  ||| S:56 E:60 ||| CC
comparisons  ||| S:60 E:72 ||| NNS
between  ||| S:72 E:80 ||| IN
rheumatoid  ||| S:80 E:91 ||| JJ
arthritis-like  ||| S:91 E:106 ||| JJ
subgroups  ||| S:106 E:116 ||| NNS
and  ||| S:116 E:120 ||| CC
ankylosing  ||| S:120 E:131 ||| JJ
spondylitis-like  ||| S:131 E:148 ||| JJ
subgroups  ||| S:148 E:158 ||| NNS
In  ||| S:158 E:161 ||| IN
terms  ||| S:161 E:167 ||| NNS
of  ||| S:167 E:170 ||| IN
adult-onset  ||| S:170 E:182 ||| JJ
definitions ||| S:182 E:193 ||| NNS
,  ||| S:193 E:195 ||| ,
rheumatoid  ||| S:195 E:206 ||| JJ
arthritis  ||| S:206 E:216 ||| NN
( ||| S:216 E:217 ||| -LRB-
RA ||| S:217 E:219 ||| NNP
)  ||| S:219 E:221 ||| -RRB-
and  ||| S:221 E:225 ||| CC
ankylosing  ||| S:225 E:236 ||| JJ
spondylitis  ||| S:236 E:248 ||| NNS
( ||| S:248 E:249 ||| -LRB-
AS ||| S:249 E:251 ||| NNP
)  ||| S:251 E:253 ||| -RRB-
are  ||| S:253 E:257 ||| VBP
rarely  ||| S:257 E:264 ||| RB
diagnosed  ||| S:264 E:274 ||| VBN
in  ||| S:274 E:277 ||| IN
children ||| S:277 E:285 ||| NNS
.  ||| S:285 E:287 ||| .
Adult  ||| S:287 E:293 ||| NNP
RA  ||| S:293 E:296 ||| NNP
is  ||| S:296 E:299 ||| VBZ
in  ||| S:299 E:302 ||| IN
most  ||| S:302 E:307 ||| JJS
aspects  ||| S:307 E:315 ||| NNS
similar  ||| S:315 E:323 ||| JJ
to  ||| S:323 E:326 ||| TO
seropositive  ||| S:326 E:339 ||| VB
polyarticular  ||| S:339 E:353 ||| JJ
arthritis  ||| S:353 E:363 ||| NN
in  ||| S:363 E:366 ||| IN
children ||| S:366 E:374 ||| NNS
,  ||| S:374 E:376 ||| ,
but  ||| S:376 E:380 ||| CC
AS  ||| S:380 E:383 ||| NNP
differs  ||| S:383 E:391 ||| VBZ
in  ||| S:391 E:394 ||| IN
its  ||| S:394 E:398 ||| PRP$
clinical  ||| S:398 E:407 ||| JJ
presentation  ||| S:407 E:420 ||| NN
according  ||| S:420 E:430 ||| VBG
to  ||| S:430 E:433 ||| TO
age  ||| S:433 E:437 ||| NN
at  ||| S:437 E:440 ||| IN
onset ||| S:440 E:445 ||| NN
.  ||| S:445 E:447 ||| .
In  ||| S:447 E:450 ||| IN
general ||| S:450 E:457 ||| JJ
,  ||| S:457 E:459 ||| ,
the  ||| S:459 E:463 ||| DT
nomenclature  ||| S:463 E:476 ||| NN
and  ||| S:476 E:480 ||| CC
classifications  ||| S:480 E:496 ||| NNS
of  ||| S:496 E:499 ||| IN
arthritis  ||| S:499 E:509 ||| NN
in  ||| S:509 E:512 ||| IN
children  ||| S:512 E:521 ||| NNS
encompass  ||| S:521 E:531 ||| JJ
subgroups  ||| S:531 E:541 ||| NNS
with  ||| S:541 E:546 ||| IN
specific  ||| S:546 E:555 ||| JJ
signs  ||| S:555 E:561 ||| NNS
or  ||| S:561 E:564 ||| CC
laboratory  ||| S:564 E:575 ||| NN
tests  ||| S:575 E:581 ||| NNS
and  ||| S:581 E:585 ||| CC
pathogenic  ||| S:585 E:596 ||| JJ
mechanisms  ||| S:596 E:607 ||| NNS
that  ||| S:607 E:612 ||| IN
distinguish  ||| S:612 E:624 ||| CD
one  ||| S:624 E:628 ||| CD
clinical  ||| S:628 E:637 ||| JJ
form  ||| S:637 E:642 ||| NN
from  ||| S:642 E:647 ||| IN
the  ||| S:647 E:651 ||| DT
other ||| S:651 E:656 ||| JJ
.  ||| S:656 E:658 ||| .
While  ||| S:658 E:664 ||| IN
one  ||| S:664 E:668 ||| CD
of  ||| S:668 E:671 ||| IN
these  ||| S:671 E:677 ||| DT
subgroups  ||| S:677 E:687 ||| JJ
corresponds  ||| S:687 E:699 ||| NN
to  ||| S:699 E:702 ||| TO
RA ||| S:702 E:704 ||| NNP
,  ||| S:704 E:706 ||| ,
the  ||| S:706 E:710 ||| DT
one  ||| S:710 E:714 ||| NN
related  ||| S:714 E:722 ||| VBN
to  ||| S:722 E:725 ||| TO
AS  ||| S:725 E:728 ||| NNP
usually  ||| S:728 E:736 ||| RB
includes  ||| S:736 E:745 ||| VBZ
children  ||| S:745 E:754 ||| NNS
with  ||| S:754 E:759 ||| IN
undifferentiated  ||| S:759 E:776 ||| JJ
SpA  ||| S:776 E:780 ||| JJ
and  ||| S:780 E:784 ||| CC
not  ||| S:784 E:788 ||| RB
definite  ||| S:788 E:797 ||| JJ
AS ||| S:797 E:799 ||| NNP
.  ||| S:799 E:801 ||| .
Thus ||| S:801 E:805 ||| RB
,  ||| S:805 E:807 ||| ,
comparisons  ||| S:807 E:819 ||| NNS
of  ||| S:819 E:822 ||| IN
RA  ||| S:822 E:825 ||| NNP
and  ||| S:825 E:829 ||| CC
AS  ||| S:829 E:832 ||| NNP
in  ||| S:832 E:835 ||| IN
children  ||| S:835 E:844 ||| NNS
actually  ||| S:844 E:853 ||| RB
correspond  ||| S:853 E:864 ||| VB
to  ||| S:864 E:867 ||| TO
comparisons  ||| S:867 E:879 ||| NNS
of  ||| S:879 E:882 ||| IN
various  ||| S:882 E:890 ||| JJ
forms  ||| S:890 E:896 ||| NNS
of  ||| S:896 E:899 ||| IN
childhood  ||| S:899 E:909 ||| NN
arthritis ||| S:909 E:918 ||| NN
,  ||| S:918 E:920 ||| ,
currently  ||| S:920 E:930 ||| RB
classified  ||| S:930 E:941 ||| VBN
as  ||| S:941 E:944 ||| IN
juvenile  ||| S:944 E:953 ||| FW
idiopathic  ||| S:953 E:964 ||| FW
arthritis  ||| S:964 E:974 ||| FW
( ||| S:974 E:975 ||| -LRB-
JIA ||| S:975 E:978 ||| NNP
)  ||| S:978 E:980 ||| -RRB-
and  ||| S:980 E:984 ||| CC
AS  ||| S:984 E:987 ||| NNP
in  ||| S:987 E:990 ||| IN
its  ||| S:990 E:994 ||| PRP$
early  ||| S:994 E:1000 ||| JJ
undifferentiated  ||| S:1000 E:1017 ||| JJ
form ||| S:1017 E:1021 ||| NN
.  ||| S:1021 E:1023 ||| .
In  ||| S:1023 E:1026 ||| IN
this  ||| S:1026 E:1031 ||| DT
paper ||| S:1031 E:1036 ||| NN
,  ||| S:1036 E:1038 ||| ,
we  ||| S:1038 E:1041 ||| PRP
review  ||| S:1041 E:1048 ||| VB
these  ||| S:1048 E:1054 ||| DT
to  ||| S:1054 E:1057 ||| TO
finally  ||| S:1057 E:1065 ||| RB
compare  ||| S:1065 E:1073 ||| VB
the  ||| S:1073 E:1077 ||| DT
two  ||| S:1077 E:1081 ||| CD
populations ||| S:1081 E:1092 ||| NNS
.  ||| S:1092 E:1094 ||| .
